Xiaolin Zi

4PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 22, 2024
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.

Michael B Lilly, Chunli Wu, Yu Ke

|Nov 30, 2019
Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy.

Victor Pham, Raymond Rendon, Vinh X Le

|Mar 20, 2019
Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.

Xuesen Li, Victor Pham, Matthew Tippin

Pageof 1